About: covid:443d1c7ad08b8ce969c24431d5971dd6c4e1b14c

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: covid:443d1c7ad08b8ce969c24431d5971dd6c4e1b14c Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
Creator	Klumpp-Thomas, Carleen Hu, Xin Zheng, Wei Zhu, Wei Guo, Hui Shinn, Paul Xu, Miao Chen, Catherine Shen, Min Michael, Samuel
is schema:about of	named entity 'IC50' named entity 'viral replication' named entity 'screening' named entity 'compounds' named entity 'urgency' named entity 'chemistry' named entity 'ROLE' named entity 'VIRAL INFECTION' named entity 'PART OF' named entity 'ASSAY' named entity 'IS A' named entity 'IDENTIFIED' named entity 'VIRAL REPLICATION' named entity 'assay' named entity 'drug development' named entity 'IC50' named entity 'activities' named entity 'IC50' named entity 'specific' named entity 'valid' named entity 'protease' named entity 'assay' named entity 'clinical evaluation' named entity 'IC50' named entity 'IC50' named entity 'SARS-CoV-2' named entity 'protease' named entity 'combination therapies' named entity 'SARS-CoV-2' named entity 'IC50' named entity 'SARS-CoV-2' named entity 'standard curve' named entity 'peptide' named entity 'ATP' named entity 'preprint' named entity 'ketone' named entity 'RNA virus' named entity 'Birmingham, AL' named entity 'caspase 3' named entity 'cytotoxicity' named entity 'cleavage' named entity 'dose-response curve' named entity 'antiviral drug' named entity 'substrate' named entity 'cathepsin' named entity 'COVID-19' named entity 'enzyme assay' named entity 'DMSO' named entity 'binding affinity' named entity 'coronavirus' named entity 'cytotoxicity' named entity 'enzyme' named entity 'preprint' named entity 'SARS-CoV-2' named entity 'bioactive compounds' named entity 'fluorescence quenching' named entity 'Molecular Operating Environment' named entity 'enzyme' named entity 'biological replicates' named entity 'SARS-CoV-2' named entity 'protease' named entity 'peptide' named entity 'FDA' named entity 'bioactive compounds' named entity 'Open Data' named entity 'SARS-CoV-2' named entity 'Edans' named entity 'Edans' named entity 'signal transduction' named entity 'neuroprotective agent' named entity 'inoculated' named entity 'structural proteins' named entity 'bioRxiv' named entity 'fluorogenic' named entity 'cytotoxicity' named entity 'fluorogenic' named entity 'antiviral effect' named entity 'caspase 3' named entity 'active site' named entity 'substrate' named entity 'crystal structure' named entity 'bioRxiv' named entity 'enzyme' named entity 'P<0.05' named entity 'enzyme' named entity 'SARS-CoV-2' named entity 'substrate' named entity 'SARS-CoV-2' named entity 'enzyme' named entity 'DMSO'

Attributes

Values

Creator

Klumpp-Thomas, Carleen
Hu, Xin
Zheng, Wei
Zhu, Wei
Guo, Hui
Shinn, Paul
Xu, Miao
Chen, Catherine
Shen, Min
Michael, Samuel

is schema:about of

named entity 'IC50'
named entity 'viral replication'
named entity 'screening'
named entity 'compounds'
named entity 'urgency'
named entity 'chemistry'
named entity 'ROLE'
named entity 'VIRAL INFECTION'
named entity 'PART OF'
named entity 'ASSAY'
named entity 'IS A'
named entity 'IDENTIFIED'
named entity 'VIRAL REPLICATION'
named entity 'assay'
named entity 'drug development'
named entity 'IC50'
named entity 'activities'
named entity 'IC50'
named entity 'specific'
named entity 'valid'
named entity 'protease'
named entity 'assay'
named entity 'clinical evaluation'
named entity 'IC50'
named entity 'IC50'
named entity 'SARS-CoV-2'
named entity 'protease'
named entity 'combination therapies'
named entity 'SARS-CoV-2'
named entity 'IC50'
named entity 'SARS-CoV-2'
named entity 'standard curve'
named entity 'peptide'
named entity 'ATP'
named entity 'preprint'
named entity 'ketone'
named entity 'RNA virus'
named entity 'Birmingham, AL'
named entity 'caspase 3'
named entity 'cytotoxicity'
named entity 'cleavage'
named entity 'dose-response curve'
named entity 'antiviral drug'
named entity 'substrate'
named entity 'cathepsin'
named entity 'COVID-19'
named entity 'enzyme assay'
named entity 'DMSO'
named entity 'binding affinity'
named entity 'coronavirus'
named entity 'cytotoxicity'
named entity 'enzyme'
named entity 'preprint'
named entity 'SARS-CoV-2'
named entity 'bioactive compounds'
named entity 'fluorescence quenching'
named entity 'Molecular Operating Environment'
named entity 'enzyme'
named entity 'biological replicates'
named entity 'SARS-CoV-2'
named entity 'protease'
named entity 'peptide'
named entity 'FDA'
named entity 'bioactive compounds'
named entity 'Open Data'
named entity 'SARS-CoV-2'
named entity 'Edans'
named entity 'Edans'
named entity 'signal transduction'
named entity 'neuroprotective agent'
named entity 'inoculated'
named entity 'structural proteins'
named entity 'bioRxiv'
named entity 'fluorogenic'
named entity 'cytotoxicity'
named entity 'fluorogenic'
named entity 'antiviral effect'
named entity 'caspase 3'
named entity 'active site'
named entity 'substrate'
named entity 'crystal structure'
named entity 'bioRxiv'
named entity 'enzyme'
named entity 'P<0.05'
named entity 'enzyme'
named entity 'SARS-CoV-2'
named entity 'substrate'
named entity 'SARS-CoV-2'
named entity 'enzyme'
named entity 'DMSO'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software